Hilltop National Bank Reduces Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Hilltop National Bank reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 436 shares of the medical equipment provider’s stock after selling 25 shares during the period. Hilltop National Bank’s holdings in Intuitive Surgical were worth $228,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the company. Godsey & Gibb Inc. lifted its holdings in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical during the third quarter worth $33,000. Capital Performance Advisors LLP acquired a new stake in shares of Intuitive Surgical during the third quarter worth $38,000. DT Investment Partners LLC lifted its holdings in shares of Intuitive Surgical by 80.0% during the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after purchasing an additional 36 shares during the period. Finally, Mark Sheptoff Financial Planning LLC acquired a new stake in shares of Intuitive Surgical during the second quarter worth $37,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently weighed in on ISRG shares. Leerink Partners increased their price target on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. JPMorgan Chase & Co. increased their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Citigroup increased their price objective on Intuitive Surgical from $567.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Robert W. Baird increased their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $554.17.

Insiders Place Their Bets

In other news, CFO Jamie Samath sold 270 shares of Intuitive Surgical stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total value of $145,840.50. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,730,093.55. The trade was a 2.99 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Brian Edward Miller sold 2,553 shares of Intuitive Surgical stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the completion of the transaction, the executive vice president now directly owns 7,066 shares in the company, valued at $3,638,990. This represents a 26.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 48,190 shares of company stock valued at $25,012,927. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Up 0.6 %

Intuitive Surgical stock opened at $547.47 on Friday. The stock has a market cap of $195.00 billion, a PE ratio of 88.02, a P/E/G ratio of 5.31 and a beta of 1.39. The stock has a 50-day moving average price of $535.93 and a 200 day moving average price of $494.44. Intuitive Surgical, Inc. has a 52 week low of $355.17 and a 52 week high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The firm had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. On average, equities analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.